DULERA (formoterol fumarate; mometasone furoate) Merck sharp dohme Patent: 7,566,705 Expiration: Nov 21, 2020 See More … For more information […]
Drug Patent Expirations for the Week of November 15, 2020 Read Post »
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA.
New patent expiration for Recordati Rare drug NEOPROFEN Read Post »
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA.
New patent expiration for Tolmar drug FENSOLVI KIT Read Post »
Annual Drug Patent Expirations for RADICAVA Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA.
New patent expiration for Mitsubishi Tanabe drug RADICAVA Read Post »
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar Therap and is included in four
New patent expiration for Tolmar Therap drug ELIGARD KIT Read Post »
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT Read Post »
Annual Drug Patent Expirations for VIEKIRA+XR Viekira Xr is a drug marketed by Abbvie Inc and is included in one
New patent expiration for Abbvie Inc drug VIEKIRA XR Read Post »
Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29 Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in
New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED) Read Post »
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one
Get fresh news and insights, drug patent expirations & more…
